Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate CancerMengjun Ma, Chong Qin, Xiaoyu Chen et al.|Journal of Medicinal Chemistry|2024Cited by 15